The Art of Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Art of Investing

PICK 46.27

-1.4%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Sun Tzu	1/17/2025 5:21:40 PM
	of 10578

VANI - This is a public service announcement. Just don't blame me if it doesn't work out for you. . Here are some more details about the IPO of Cortigent Inc., a subsidiary of Vivani Medical: IPO Details: Cortigent Inc. is planning to offer 1,500,000 shares of common stock, each priced at $10 per share. The goal is to raise $15 million1. Trading Symbol: The shares will trade under the symbol CRGT on the NYSE American, pending final approval. Company Focus: Cortigent Inc. specializes in neurostimulation technology aimed at treating conditions like blindness and stroke-related paralysis. Their Argus II system is FDA-approved for restoring artificial vision, and they are developing the Orion system for broader accessibility1. Parent Company: Vivani Medical Inc. (NASDAQ: VANI) is the parent company, and Cortigent was formed to advance Vivani's neuromodulation division. The IPO for Cortigent Inc. is scheduled for Friday, January 24th, 2025

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next